ࡱ> @=6Ayٓ8UR41ޙvFx}ǿe!ZPg eLNc:gJ$I":$%{^7(v0$fKk&e,.Vފv9gN5sg콿纯&Bk8R+uTFIE'#CS%>Sn (54ѮV!cO0?BO@|(VLʆU_qvXfL/[4V1YX!AǙDV /]ʡvPߠ ^ڵ2cj[]E.~ES|rDhD\+/y<5S|VM,]'7^7C1aGr*u\ayU k_݃}m)].0¿KqͿY[Ek|>3C;6t1XgJIB5먚Au_S3h V!bcwx蟐}a 0F8S )ZsPʡQTvWyѫd?)euE_},hRX_+`gj5 :_\__}A{}}v[÷ioVߡ-6zNe.l=Z{i(S?4|?y~H=O3<_SRQciWP'O^'zYun9uXI-WSYQ]T  .E3vI' !`9,4H%nLH `z=OAEAΫq)~TC;zPΨ*p})EIE  ]qw:c::ryQv頲];{3l>ӵڣ ekvk+Sˉ^o9{;^Mi\5_[MCYZ=N)SKMBd՚ϕ`%gz,e!&z( PRtI(dl*T`*FGLE,U9[Z,ҝX-]ul)ʱ]l P#[m T`϶eQ]jj{uՃO ܎!*0jA%[RVHkm嬍dv*ΪC-ko5hhM5֙\b],zS==ja0 #M c})0 fA*Yg73YNL'p8 ˂lr  $<"Q+ jPz5hjMwbw;Zw`=IooO{;}XK66[Pdl16onSm?`~M-͛ا>[ U~-é7Lo`.l׵^ǶymwZ״^v^f6v,o~ʖ,+a`GF;塬 P"혗!.4?z_?OïǷ_c$m2>7Mf3Ylq>9L7??B4 'bX'4XHR7s?qf1L~fК^xu.DΧBi>$xFx1{`,|fzُb%#ٗYV<xxJf^g^cGC!U0zL]QSJnߋq@]SBŚ\:Wiz#96Ur%z/U~oP&! 7i#վV[WiB}<컒+y7"(@=P[sF92a-H1ޙv^>xYkW?wv4#Jc]T UPꢘZĊH1Zi d|(U I[e!Ñ>h `%4FiaXStWf}Z,暱\g^h׏g"kЮwwS7 4>8D˅/˴TY˼ǸzIrB^VGchݠBu}U`}HA::p}71cTeBφ١P@#U@P-@=l2{$gWQW`޶9!2es61[ Bb.֐3lضܛ§t܏ 3 4dzw7-X 3iܻ/ţŤzkݤ6Sc`|c?}5} ^y bt>=ؤ[,^P~F3\S3[Rh?<ߪw^q9?ʛzVn<7z_'Pu$zyɓ[?MfG;e/;~vp/8s~G_7;*WUrG۟)I9=&>- v?uܽGY*-ru tTR; *1aw|{{tG-Ypg1;}FٯbK{Gq/\궽3&[RM\tn-uK|3m7}݌``x u܋~;|{;1*qa|; auXžlQW@֗&elͳ=s2N:dt8M{/0o!Ol49_ǩ/|o6H3t4D[ee``_=Q5}9=Oqd}X-|J"\>k>YY 8AlD8 bV ʹg«sއ߉_ {Ϯ@m !YKygU[dWԼ=6ODF$rၗf@=F<1^ZraMo`#1 ޙv5L]xZ]lU>wvfC  (ƕF- %$B+KehAӔ5ၤ&HDۄh&R1 B=ιӻ34vSr{9ssLt:qN^C>˹|d1)tS_".o=n|%\~eJG;Ag見~}nƱ% n9s'v-{֙uzAuw#[6v] L|Z2k4 f.A޳ԅ,EŤ5,h≨92o;]Rf! Y>͕}V=ِmQdP\뵼iܭc]'խFpk8t?D}a`د6C}#x. w #>aؗeZ1mZZ3}1G{9hzO%9g&7=Wf/zŵ}r`48!q50qom5q!6b5 "ʐpE]q)4ow/ gqG]\1(Cwu mߋݺ54RQKsk^Fvqm׵LJ8d_Hs3;wN +]4u:Jq9 ] u%]\1(Y:%l]=Wנ~M"~T}")RSAX~-Gpn9#nR ۯ]_뺔JyȯFrb+崙\6K گf˻ŋ%tZЯLi}3}2*ŔpPhupgqGи:qXk~]_)>FEiJ9{u\IQ9/hh<.(*zo0kojEAAA(9pEZ)4.lF5(.](*_ץWk‡[Ոk ɑݯFW(Jq伐ո7z]޻PT,ՖB~x&}Մ2(r^K _"N/иګqO{]ޗQT,5Kٯ>rV;/9|ruM{uMc.%vN|ո{]ޗQT,~u Kz9s@:wxysNA5=tx0Q/5<#T*(hǙ棉}67 JgF}jb1 +O1Fú.0> ckVU(y̤5gt=ͯj;]io\OZ'yoq1͗Kp 1~7E[\wNG}db)]X)M%Doo'|xWAS0-+\E[񮁫t7!g0$Ӹ4e/(N䃫tyہb \->x0A˸ ZߠxXkU?wvҍI aHuf&vA.L]R ؅I  tV0&ZZ*$/y#Z}>-sfٜnP{1cEz7_B*d۠༒ǹX< $Y$;`PxL]R{d?D*޼ n7Γj'\ pЋ#n1C?t3[7R HlۍF<ϥCz6zWyDFк'>5u߈f; I|{fp #q`x~~rʼ+Y2;&? LGaT<؁)H'fvWoM⸔lk t=&iD9&}i[H>wѸ2̱7*Q3* +;UJ!;Uk3c?ɞ{)q;q\~;FS-wC7ȓ2to ~:}t.]4'n_j~qFqDqBq@q~H%.9IZ##[? nqdFNĸrhs=F{ 6%Ɵ/uf @,|m!V[kB?ߛV>5_4iK<2sWeIvBk1{ y)k_wpĝm;N ;1^Y'*nCM#|B-w~`}|?@=j|`] Q1ޙv^>xXkW?wv֤qƊF PŔ!PRw6i %7pSk \*#$ދ6$Ӷ3^e"wXBy>گb [|m5# yؐvVvns.R3Rl-¾#2Cc"}h(iP=;w އ@.{ ߃02CG^g :ukaփ(A(0}"N]p(HOnN %?DK?xQZA؏o.O}ϩfy@}H| ިؓ^T3Vp~1;T?f؟onMbO{۱w~'93 5t[Z?|G5:̆j:֐ʆelGj wiw[+%l¤^'Yسcذ|_lA|~#b 孝0osi%VOC)97TmmqF7T6Է(ELB^io789ĝ \JcmG@|F[d*m{N>jϓ ΍ Ή ΅ ΁ ]M嗘(O0O7įpHƈw޺O>*Stb'-2B'E7w/emXoc1w1s0zb 3d p 7RGc0:Ra68׆DǩE?ir߹Z'cjoe$O:Y5#{_߶=r0煩$82/Hϥ8ou<}OIIxYxXOle.RqԥPhj&)BT$=@ZJVS'Ln=h&I .Bȗ>L-Vt>q3;Vg/ẔgnY_A[6orֹMx?:᛫owtަzZKwZ_8FŞ{?}^>ľW6w^z#Og6~?3d?HIĞ{N l79ղqcA&;`'!ץ  EI -U۵TlzUCNVVVAe[T=Z/AI؃kY 49';,O2$Jp}z]6Y_Wuz8N2;4Nip%h_r|ϑ_u8YG>b U.s*֍Gf\526ucR#֏l|R=m|EEH%먩Q1%ӁT64])QstۢBM̘P]nIsKNRwg9aY g꾇~Xt.[\mַܾ kH.ۼEo={CևT64w(EDL^iM!/zӨ'z-ѸCPL^Scm>{w?8dWz}_Oǽ*< zl߽&^Ezj$>a"Q?k|ٜXt;spp^ȡQw!ĿBs#MZp~?+qXOi\O_7g[>о B]]Lbk~BSr8/mҩ{g΃oOq# wO} 1c9tOS 0eו@=I[d]Ǫ˰xXOheĬI!n ͶMbܖX]Ql\bXKҺBi(!sؓx(`L`BrAAPv~nQ{E!=ԛ@'NNH |Ay%s'OpdAASH&=D琊,.ۃVBw 8166xH'O8 D*ihf0|%!HI}MzT_*hZeCQKiix pW^a_.Ag= CAt1C~lՃʲFy;0QY|CG`Ӈg_Jp.,7 FI x{Ճ:G_2M".>˃Sڃ<,{»Z6}~ecoTɖ;gUVww\3ƞسm$ĞtJߎc!ןNfQTƭ= 1to":}t.G]~Z./҂#U&<[fMVհ7Q6YCNz[qۢiL ZVa?S[k,OvYdH7ATl~Uqy~OQq-vhU~Ȓ7U~ӲcK~Ւ_/Xg-~K>mɧU 1~N>izVjퟮ q'9^t[Z?|-3HMע5E3m.3HeCm:ꖮ.˶}n MP@n{I7餶Q']wg-aMf O7|GaNsivOC!>7(^|[r»N3KFQۋT6Զ(EDL^iP(PR@wW(^ C[gw[U9!=O+܎;7*܎;'*܎;*܎;*܎+w5}F*q3t5q">]|$0.݉ WΑ99 6V 6%Ɵ/ul @Sm#V[kBS{^nZǩOϛ> he]. gO!c1ޙv^>xXk\E>s_ݔ56Ѡ A.-Z 1<(dqM]P5DE| >` 1߹콛 6N̜393]VHK(| y9󗆈mHA?7ef ߸˶{N8-ղ3Î훐a=IPRu`nw2a/~Ag uC!+#pUE.5 18Fm.JtD2B 'vmKQcM~ab@+:o4IzޡYDx,MQm{'Uz=Fﬤ+)߶S'q{3_Za\/)|_SK~61kִ*k7__iʧ)b":nɽ2ڨu!n<ަm\];(Xc޹?"-&<#z- 2m`5ω_9S5'gZs=)k>Y]]-=sL\}q'$:Şyzb6l[x>1~țqq97&߬Oʨi g_SuXi׸Jc3ו9ӤcC R{]]?~]DŽ]GNW=pv0uE*׸Y/>غ.aAK%qxu{=OҏewOJ?^~=,+}~<  B-^J,ZhYgدcMwGoW*~ s{*ߣ(?῵/F[N4ܿir=M]K_v7N%?֏J?{|2uU9~<+̢8MgiIJnC̗%pȡ>L 0Ia7kͣ,ȏ;TrҺ=rg3|4/)FX?Dк*<90a|`g~}tG_o,(F?~is=+pFn%_-21u="@==23L'xXkTW?͋ 댕dNTp,J렘RvHEF,@S$T|Shԝ]t[H6Iݵ5 +uaΙy/3J w=gAz+_G:>~b@O/8 4+89Ń]&`?"!>;݃dz#Hs<̹pT\{9zqA76xH'>h:}lзUkr Km"u \Eu֡u"]2u'TON靂/`.e$g= S8VIh푸Y?lϯߚ s f@v;ؕtpFi΃"Np1"-S@vd$^@ å.oiH5|fi\|{+}ŠvN\$TuI/hNܾx@@*l)-+ v%S6ߣgqq)-j9Z/TQ±$~|"˓ v%ͻq|:.b_Suz*'gi-?,h_m[K%ƒe'-!ϨܧT[3]_Ro?r\awyVM^K%<*:4nV}͛ɛqE*ꋮ6QtYE#5wByw[8JI'/:iS=  }{c-^ދüGy9{\|o$Rmg=g5U\#Ugv+bC=D\bJjk!C3HbKT^vkj5='d ssss}}}Wg)9dѽHGG'}O>`b\*a1;rhs9p91M ?_h1,|M"V[OkB??F>5_4iK<0sPW7k9־!wt;Nf΃oE#63Ml/nu#|B-w`|/U@=ī+.`k\1ޙv^>xXOhencikڴARXhFl ifJbYK(H:ל*4*A6\Rr(H)h/c+{߼7yLv:~o@p@0p18Jwg~@ 6ȼ H{g"޳H#_@':iQ'KmqX,n&H <(;aжv1T"ynj5EjG_%ue"gѤzw]x.U=QƱ2LAkkOX\,o/ҹ)/؁HNO̜qI)霾lyo ϧ.[oҏ%Y&6yxeWf~;P>W3E[F}Aw|߫| s}PFo=wdi!i_،gIT>j< t,|FYaN,ZV ;&&:[cU3YlyUC}JOzA[R5Z.B ؍c9 Y'=O<ěV8KMu~*O2,I5m;n?OП᠊e^ůռ"#8L˝:GXqtDrѾrFg~oCe0 NgYuTͰYñHeC}e5GV-.Ԕ\5/rW$dR_IV.,%#:,)ۗ5#х⶝kk#ɱ46niQr.cm#jms^tX;{ Ƒn$QR\EsJn'A"VWkDJ\i.Zvmv#.IqMKۜzj7[ds_~Zp?WV=42[8&CpH樾kؘXVSh[eSp"Y]LaF|k~<&ԔKvdڙ&oOOk잍;{b#|:-n^J]|SO@=m%,<\1ޙv^>xXMlTU>L[P' 3cQA' 56M% 3`5!vUî .Ӥ4%CQ6K 93=s^g%KN9;*A R*@:>3`swp <Og~OBC/½lH{.-1y1/&!p}NTb{](z7Zq"Y#yq8A:&P,]`wZj{$5ɶ# -Bw>L-'VuԷ>q/XRiy}oZo/%Y6Yp[07>.Jh\l`{yGgorc/g6̿:$S|O='Qf<ڧ7n?AX)`~6vb؃<.yX$TeY/hM\]|@D*lێUeЫ*=YYYiЇƇnQuh3r'a/eS_瘟,3?o*AT:^7u\6y,_WyzO=4Nit%h_r_v/;{ßU>AC*9VF#ăr3.wvN];1ɑVGßT!P &[2붎ŝW2HeC}b5GV-.Ԕ5T]lI}eK=ORvg9BaYپ }gD.a܆Ǣcilro](^F|9qlG޺q{mG*~$k"&FQ^ƄEnQ%jW{ +T[ g궇v#.QqK۝zjZds_~\p?WV=4:8>C'H樾v5~lL,nqKmq;2pXP(߁9&SyT ǚgP~W#1<MxXMh\U>Lim%NӦ Q* KɢPIZR4 >*Ptᾁde7bEWґΙy/3AϹ TN "eRh< 3ѳc.> pwASuS@ks4_8"!1݃dz~ L{iy4dIj :bYtdt1G:Kyeu"M9s^>nH.R'&o=nmGx -{-C^&ճ5yop:|O<`{՟ށ?o,/0 œ0[>XSǩ?>|a}2KJNv (~4>tӴF%Eh;p,$¿gx3)P~Sez?u||o$}Cf^_fGϷUßss'pH2n|xxPn&ο#cSw12!9nh_{#tj?ʷu=l:n*fpRP_deXFݑqt u%rE6pdL+[yQ>1UGb{dO8#Pqm6:Kc㖔{-B{mU[l*0RP$Q\\S q5"7EW,ɢܪ%jW{ J+U[  Gv .qqMK;znwZds_~R/s?V=4<8yFS!98:?67ϸmq82pȑq!¿[oCk-g6OYH~/?s1IxۚzWyz^45|[7 m̵uZ$I"_Z_߄>&ԔcK;vxX2uL [;S1g/=Mi>Cݖ{@?n>_)@=pj>DT6U1ޙv^>xX]hU>wv&)a1!mA#jahCI$jZv@CB>>TC}$\ 3sݙԁs=;wBjA,+\ ~/QH!>q7fur_@/"' w`I5@L${ ielhdu8ODTmN,O{qNA`㯾0u bP)b{sm.RҾMbnU?ZFbHEQ (L;&C=pq, Bu{Oe-;s ?u̲ɶ#Mqy8F-gN.)ҳ8ٓ:$ZM$#i/:pצڟ>fP zSm!5\S;p㥎h1y.2ҽlS ܚ=j'h\ͱWE[FOΪ趙zQ 8Zr i6bZ~Es%>4*4Yj(k{blZ=4#w#qY(ŝ8 O}-?d$C51"׳1qnI}ce~gYn'J vC66bF>6jgkdm|uT[?2Vڀ`=DlSH? _ * # ֡&Jlö}h%A׸KZтG(?[nˏaO} h}?GҶPpx.j2]32vy"I|_Tͪʪq;*o'VyM"8k$$7w6I8h}_DҶTW}vڅW}ڌo}] ]Arz]G׸uM;WAwжTטaq+ǘ此kArU޺uK^. =uA |m k]z8_TǜiG܏:u.Ks?<"!=bNtL}DG?ϰnOo{XoWb[%==;ao;(*?TAYaU DK菪 %A/Jԗ >=g| d|4o> 9ȀKzC9QeUy [`Mz6 Dw4}p#(lhhc̤Un5Vnf4ڑF립H=ze2cDd_ؤyb>2WĤND۹ S~y];1n3KWS(@rZ<{̧3]@=h'ZM,1ޙv^>xXk\UswפqKwkkبER+TKCV 6 Hٴb*JrE TJP1B%.ED"E̓X;;{rovza9sϮ9ǐR 4oi ?v``@u@j$x'("!ܣpA2m2;D&Yw4 :V]q0S"4d%C3/<;ݣiBS7ca?{y-ԍ4x=|3+%aνQ'_Cϫ'T/VOoܧ43I>3="o%zܓM=;Vxv::Z7<B)`4lQ^C#̗}yZ$myY/hM\_[@ Mm3YhDq ͏(?-DէiK: jOs_`}CQ9!eK~_a>ڧ'Xo$sC6o[v?[-C~Ϫ1?ވMNգ}/AK{-n/5/O};IyA랥TSTh$};L3q3gN" Vm[9M}MmIsKcTz?ú}Ab=/T+úMFu{!B1:6˩ĶWf~,9U]@*yMUDL]iM*iFKѸ, {U8eNk>.}^'YYYY뻐VC _{DFy3l81 B{-\%v%crs5_:?D~~ZN+Ji\O_1wEuk?h:VuڧrB_dp/yZgz/w^Mݻ:v1'Rp _~7bNcgx,_ә@=ꌬMp6%U1ޙv^>xXkU?wfĤ0KY؂[ KK#mXv!۰I WA@?XP|)B7ɻie=gٛZs~"吞Cp>3zH2LwAy%sx. &Y$;dPx/ʯ2ɾTdv3>'1~j NE^ M >ҙwߚSoF`S6f ~R!H}H7eqc<"uhݓH:=bG5+p:'a0 = TPvitpFeч="N=pKIF(?m$(g; ؆Vk_zZ /4.d9FŞxbQw؏?8{#v~3nMbO:%4nޱ7/$ܸue>yc:"A: t.\F]AJ./^ ?f&:[ Ǫn=.r0QNsi¼%vOC!97Kp;7f|FNFʆv&^߉6^kxiJ+Ҫm߳ G~Ė&%~mwzN>j~IFIDIBI@I~H%.sZSt5I"unS s qӌK%3Nw"=f p^ #@'lſ;/21]_bR'O ~Kn5ٺ&4iS_Oϛ/1[ S't["CqxXMl[E}~$q4%i&nA:- Ԃ*6 mRq@P 9P T! 7RB9 72޼8@x~33)GCjCFS?kH:OP w@Ӊ͒.>!EB*AI-GJnWʅ ׁ -FOzQuSه8ҙg8Є aMj XԄԵ[ kXct i{鲢YMB|l,A.i|= =f;}zvnX\}9=AP^k{^|Eƍcɵvv$u,i(ġ&Ii=0[9]qM􌶟WxoT5셷tE/b[7I[߸I4'拯>3_mzSܫ5s3nM,y1ץ|KݰvWcIb@t?BT9Vi7hLzNIA#7ɫUgRQ197WNc]}ؗOm_`}3CQ^|yn%xa2?qGXdsXY}//Y~~b߰oX,Y K?!#r.]o2fGVk]SNl;65Uoɹ`ZOJmj- 1k b_R^UĺuZ[[>BcY^o"7MO*׉+bw!iǞj}0݋ _(ox/v"KV{s>mRޭ#viYuAMV$R^Q{+yuJ+Ͼ;v&7S"HƗطkn%e4Џﯜ-Wv)o,`ndnYۛ׬}L^HƗeEVrߜ8#p;{ ?>=sr']7sE~ORyb1J,Ѓ pQ{B%}DŽ]) o^r<7Y1pUwo>Ez+fge'nۏr'Awx/UJGˣ$yco'r@=_wrW^t2`1ޙv^>xXOhelm6R״-J`F X$%XR4 *=xo rROEhe}6od7Λo@1l3+tp7q:ʸW?}$p>a$3#0kHS,;V!ppT,{q/C76H^yaμhз4"-<[^Kc" mɶWDFк1u_U= .[6 ѫx_4,ZK^{lt++@ė/Vvi=k:x c}8m,⺔Z[_CӅ6|#D9X卥ƞߨ?t~5DKcoTɿ;T3NGU8'Sdq{;cJbO:%s򐴎_MfIϩM{A*a7l8bx]("йȨ1B/hOZ_|@CR]f3Us׫Svҵa+ے4zIz0@i. ';,O2$UGqz]vAs_'Puz'gts9*tʯ:v_t/:БUL0Ѹe^׺"#|Pm?]#lPqzJjѱrȑFITC-_'MLTLjh.:%K5X&nIsKNwg-aM mco#GlTr.[ZԷܾ kH.[Ӌd+V|4""U 8J%5W#zs^PO6-ѸCPJ^Wcm^={ IlIk]^s۾/}'5|i}s} H3H"j$>D£sm5esZyƭ^= /.9Wvs/&vo3Mλ_S{'s#N=):oH,0{<_i1| )ׂ(   y 6 Chart MSGraph.Chart.80*Microsoft Graph Chart08 Chart MSGraph.Chart.80*Microsoft Graph Chart0d9 Chart MSGraph.Chart.80*Microsoft Graph Chart0b : Chart MSGraph.Chart.80*Microsoft Graph Chart0`; Chart MSGraph.Chart.80*Microsoft Graph Chart0f< Chart MSGraph.Chart.80*Microsoft Graph Chart0^= Chart MSGraph.Chart.80*Microsoft Graph Chart0\> Chart MSGraph.Chart.80*Microsoft Graph Chart0Z? Chart MSGraph.Chart.80*Microsoft Graph Chart0h@ Chart MSGraph.Chart.80*Microsoft Graph Chart0VA Chart MSGraph.Chart.80*Microsoft Graph Chart0T C Chart MSGraph.Chart.80*Microsoft Graph Chart0R!D Chart MSGraph.Chart.80*Microsoft Graph Chart0P"E Chart MSGraph.Chart.80*Microsoft Graph Chart0N%F Chart MSGraph.Chart.80*Microsoft Graph Chart0L&G Chart MSGraph.Chart.80*Microsoft Graph Chart0J'H Chart MSGraph.Chart.80*Microsoft Graph Chart/ 0LDTimes New Roman*v 0( 0 ` . @n?" dd@  @@`` ,$Lf      /"$Ayٓ8UR>"$[sF92a-X>"$F<1^ZraMo`"$=^u]U '-"$j|`] Q#T"$}6m)Y"v|w "$[d]Ǫ˰. gO!c*"$=23L'DT6UD"$h'ZM,J"$ꌬMp6%U$O"$iڱi2'%0T"$_wrW^t2 Zc $@fff@7uʚ;2Nʚ;g4\d\dv 0ppp@ <4!d!d` 0L+<4dddd` 0L+  ,Nmero de Questionrios Enviados e Recebidos--1Nmero de Resposta de Acordo com a Regio do Pas22YPorcentagem de carta-resposta em relao ao nmero enviado de acordo com a regio do pasZZ ^1. Voc aprendeu algo sobre Imunodeficincia primria na Universidade ou durante a residncia?__ h2.Aps o trmino da residncia mdica voc tem ouvido ou aprendido algo sobre imunodeficincia primria?ii.3. Atende pacientes com infeco de repetio?//=4.Voc atende pacientes que usam antibitico com freqncia? >>c5.Voc sabia que pacientes que usam antibitico com freqncia podem ter imunodeficincia primria?ddY6. Alguma vez voc j investigou algum dos seus pacientes para Imunodeficincia Primria?ZZ 7.Se voc quiser avaliar um paciente com suspeita de imunodeficincia e necessita orientao sobre os exames laboratoriais, voc sabe a quem solicitar essas informaes? U8. Voc acha que todo paciente com Imunodeficincia Primria est gravemente enfermo?VV N9. Voc sabia que tem tratamento para pacientes com Imunodeficincia Primria?OO# n10. Voc sabia que pacientes com Imunodeficincia Primria no devem receber vacinas de microorganismos vivos?oo$ S11. Qual a maior dificuldade para investigar o sistema imunolgico do seu paciente?TT(L12. Tem interesse em obter mais informaes sobre imunodeficincia primria?MM)13. Aps ler os sinais de alerta, voc acha que alguns dos seus pacientes necessita ser investigada para imunodeficincia primria?*Envio de comentrio ` ` ̙33` 333MMM` ff3333f` f` f` 3>?" dd@,|?" dd@   " @ ` n?" dd@   @@``PR    @ ` ` p>> (    6q P  `,Clique para editar o estilo do ttulo mestre- -(  0t   dClique para editar os estilos do texto mestre Segundo nvel Terceiro nvel Quarto nvel Quinto nvel.   e  0y ``  >*  0 `   @*  0Ѓ `   @*H  0޽h ? ̙33  Estrutura padroj  0(  r  S bP`  b  0 BA  ?C  b  6bf P7  CEnviados =34117  6bp  KRecebidos = 3047 (8,9%)H  0޽h ? ̙33  @  &(   r  S b0  b   0 BA ?@`P  b  <8b O  ? 70(5,95%)   <Ԡ 9  @ 413(7,41%)   < @   @ 119(5,05%)   <  A 1984(9,46%)   <b u  A 455(10,55%)   6b <  :1175  <ܧb :  :5571  <@b T  :2354  <4b   ;20963  <b   :4310H  0޽h ? ̙33  P@(  r  S b  b  0 BA f?Pp f bH  0޽h ? ̙33e   `(  r  S bP  b  0 BA d? d b  <\b   >968(32%)   <b* ? 2050(68%) fH  0޽h ? ̙33B  p(  r  S bPp`  b  0 BA b?]w b b  <bJfj n$No = 622 (20,6%) Sim = 2400 (79,4%).%fXB  0DԔP pH  0޽h ? ̙33U  (  r  S b  b  0 BA `? ` b  <tb D  63%  <b 797%H  0޽h ? ̙33U   (   r  S b`  b   0 BA ^?Q(Do ^ b  <b^ 1~  62%  <\b9;/Y 798%H  0޽h ? ̙33Y   $(  $r $ S TbP  b  $0 BA \? \ b $ <bP  p  89,7% $ <bRr 990,3%H $ 0޽h ? ̙33Z   ((  (r ( S bP  b  (0 BA Z? Z b ( < 7  937,7% ( <H~k^ 962,3%H ( 0޽h ? ̙33Z   ,(  ,r , S b `  b  ,0 BA h? h b , <b)  953,8% , <~C 946,2%H , 0޽h ? ̙33V  0(  0r 0 S @b  b  00 BA V? V b 0 <pBb  779% 0 <0bv {  721%H 0 0޽h ? ̙33Z   4(  4r 4 S $~P  ~  40 BA T? T ~ 4 <%~ "   927,2% 4 <|)~4 972,8%H 4 0޽h ? ̙33Z   8(  8r 8 S .~`  ~  80 BA R? R ~ 8 <0~ ,  921,5% 8 <,4~40 978,5%H 8 0޽h ? ̙33u  %<(  <r < S ;~  ~  <0 BA P?Pp P ~ < <h~,  FTotal = 4983 respostas < <?~D ;35,5% < <B~&  ;32,8% < <F~#   ;25,0% < <I~   :6,6%H < 0޽h ? ̙33Y   @(  @r @ S @T~P  ~  @0 BA N?} N ~ @ <V~ 6Z  80,8% @ <Y~3 999,2%H @ 0޽h ? ̙33Z    D(  Dr D S  ~  ~  D0 BA L? L ~ D <l^~    920,6% D <a~; 979,4%H D 0޽h ? ̙33  ]U H(  Hr H S     H0 BA J? J  H < D  535,4% H <` 749% H <  85,5% H <eh 945,5%H H 0޽h ? ̙33 $x TI239(8Ze>*9@ӓJӞVCIԧ9,lbf2'6he)4k[~9giϱ/U9|]TiO6*tzRy7ЏA$BisxЎw9ּtɽA%*&='KBN]-jK63;ƽl߼^kmHGY>ej"ai=_ڏR"z߇TcUykď$:Kveh_=tknUn>U%sN'eDՁZ&j: `W !h&)p 4h ZAkC Tl#@G DΠ FtA7~ < ` u%z<`x OKNZO,{=6  n>a ?7׃*x܈O. /U1O%o* +1sX( nD(i.5 °U*uKV+U 6TT&^nUwD:+j̭iK Klϰ 䜶e#a< EL}[(vϭ7~7+gӾ("_Qvi"3=&-Z2F]ӫKiE7.b"mzבv?k iJJtn:EDRnMz̩tZ2NE.)]IGtn"rs!GiE:p@#ϟtv ]YW 6|t2G8N,EǵbxPCw6/o 0ʛ:B7!~dYz<)iDrbBrd;eEbŻQ(AGm55~z$Vr>]Sv{CR5T:zەmXl1F1 2Dd]l7nrT>Jr`&&9fJ94呶J?.E[@ڑ۴EގͭmNg:\=#DL;8;,>V Krc&isF nch(VSVϒڮ#HC?Nt -X\0BAWQnejk?5t wQ-O n Vzo*d tG,~]#sUgq̧.ȷ1 և@=WE24} tp0I .= \QKT[r3JyXJ U꯿ه_uݾ:[Up۝/"tw4'NhU )kw{_6{ʟ&6;Jk׬pnw)=rii\m<]*k Zȯ,ASMq_LnE&/A>*w6w@Jw6= r4ŁG`DC '40s`{rܨ<*Pm4_l *`L#6:+iN'tR>g/|NGd7tC'WݒG oh9L["Gh Or>)'h}ӴT"9K ͓4W h\YM)M.*(E~DFO4R~aIL %R7-Q{VRKAcBA\T"|ŏOHu>)ig>>+|^|7HE<+t 1JZ|,Vj{ 4(`wsˍ 7o(xxxxxxxɧ- 9^t Xxձe&&o /o xgS'«Ow /?~ T㟈 CtxQb: D=f"B4y Q_.e^FyQUDB!CTzMDVo!j#z-D[hQm)2Dv+V"B@4|Q=Q2 zfut/ދt( ֠{.ȀUлWho~KZDJF5ВIoB:-WуW0Ηѳ!1Hfb^^(g`1/`6 aayyuHzā =DD[ N=q BFH .pfM ~7of͛fooi2D) Yl"CWq* x뀈^ۇ[(a3Oe-"ƵR>u;υ/nN9FSYO! s?Oc^^GyL<,?q2)uq2 #T/in*KNmoG>ۡEؼg|e+3AZ 5=x e1j.d*//!y% y_bWfd7{|{ϙZi&<[UVl RO%m51ǯ˿Οf xX]lT>3w]s׸$!?P 76MK nT)/t_VmJ(QT}C%Jr}woٜritUcKΧ~d?OЫ4hoyNՎvaizc:rGU϶.u}R8:RGW6m$S^`| <<lf l@ lm`o`:. < 6@7px8 zH1{@/})O ݛ9Qcvzu/M IhZxs4=53?:6{LY]Ǟ*%}١׏ϾɎ{Ԭ3w=sP}ؕDjbMbїhM[vdv?7OhlÇB2?y!,o vd@avl핒ZD9uHsvT1'wDt``B=zho!Qe<+zyzC[C=;.!J?8l8F9 +s Έ w8 VP?z!鱙n,iѷK<FYZ< xv3|ns-R"ޠOTnT;ԑa(d /q>WlvJ4;;i\VRnSQT%/dJ9T>E-˺%́iFC}H/^DSW? @˲]Y:֩ ge.es~NJlA7\|B}[_:"2;4ysJnόM88 *_tkU#s!sҍQhk"OK:X պwV y6Z0-]7!G@:"xn07'#js$(, ޵.I {Q˷q1"wN%+,ץvq1 )+kݤg#dV-IFIzO*"^ĊbUՎ˽<'Wl< )ӃfΎNhW/7LFǏr}[O+w["2Nxgb#hQZzh^ye)'NNqm;>֨ƨRAm/#ǎdܶ3w̲1` Kk;`LC il{c @_lJV}j"")mHPdԇ%ZՕۦRCBRwRrw7gΜ{^ިMнL>0PK$L&cəO9 ^E@^eCzJᓦu(ct5X *1VH*M}l3?Sp)'E\M%)Y\YG0?/#5ǴRoG|l<\/l7 [ݾgml\lV@TN:sh=Pl& Ā-@z`+l3m}hvn` p8 |h!ۈZ6x8:H'm'pxx y NO'px8C7mմ<>?O%ӱαC#Cci]O '+%]Tgl:@:8s){3ul{ȥpeồ])i:W ŐȾxO],^ws sjBX=_ 2n[MA}0v,9Z { 5rƘ#k0NdIq MX*X_vX@ -hR{\`5hmu虶:rQDe&~hr@S?{Do q}#n_½G~|#QM?_ԃTŷ3{OmN<ڨsK]UuҤ?{(%v}jH > u)%ߦ;A?\I&?/q͛=7EehffFJjZF7MCQ0=ES,3)Yw2C9͘Pk׮d')1T;L)`t-SH7DB@*ՕXܐ iWaϸa"BjwRO068> }Jryt+c!)Q886>uXr%I(}{߷jdK;!9LzW+!t)i=Bsn.NC-z>"ޯH`ʳ. 2e!A{ HGMpؘ"/u[/R!>B䕺y6X|hz.c)iR5mǴh U^%|דzٓS⌸D_>h;x$bёHY>2 O_gmv-S%[4,cYT]Q$=ou.ջ1RA|?=@ĦՂr|ku t>lPXG#Xo-ۤ$K8yqk8D8!o1gWqj5V"cy K2eۘC_AF 㝳wbډOeDqDAc+|)z_P)F5tY` & e/'jun4",6q@6sRK<qDzc)V"*7n[&$CTy>Y}l{^ɤ#b=ќʻl兔SWӃ#n:vO^xz |дhvy~E bJdxAT,˶k0Zb[$?G)ZNo- 1Z>!Y*a')-.QJi֚.ZkH?Ղڒ(0:϶v)eU ؑ Š$չ\m3z.y-{zǼZQH-D*d|=m1tvim}~[>>۷k+\ x狋|X*>"-&AMH ~^*>r@&+\2"ֿ՞?"¼) օC%)""=[KE"pGkdMwr""#"ֿd/# jY"2LDKFHm ~XA6B b9|57UV?k}̣e+YZ_hj^khz? zk/k,Ǥ{ /@4=w2H*([Lh팴3y6/)&˰Ux1*S~`My \)ڕFW#^Tq*.+kx_,"ϧOPZI#sӳ:|Ww{3"_d_7*$>-W`Lv9*6|z[6;MzьfX٨_6~Nۈ  xY]lT>3w׻^p1q!?b06Pum6 ZJe6+v} RT$M6mDx?P RJMiJ xϽwxJT99gΜ937[>erA*4aHB`Ʌϟ7Pi0w5q axUxW5@}<eHI9bO/6˟>ۍ>ژfV\X47:hh6` x4@hZ6O`'e|ƻ }@?O{/gKF4 gCa`t|xxxFcq0NW>ƋN֎YVqff$4-9Fg䡩ʮNg2O+%#'G1{g^ d1>验_~CJ^OI"jbM$r:֞lm;N{vGS9 |clrap%( Kval/,jqٙ^x ݪ$ơ[e+-1Lx ^*' bwL[%C#PF^8j8Mi ksnM w8,VzS?ﳍBZw 5gPPm@ciw5N ޳~O {FJ,QFHFIW.~7nݺyJiy@KKKOF Jmr v<&yYw@e!ʕ+(J3h)+EgZU,s#$K)Ԝ8%[Q!>}ͭ_:"*j;4w'Rgt鍿AMLJ| OO9Ʃ3\vu }"8H$@Ozep:3x/[nBNtX\nWVC%N0_qt)9Tz;^FRchW^̱_>'V{=0b鍈`t=I?Tef`Qy\#~5'<~YÏTg ?8wv:$IW.BA^G<Ԛ!ֲ¡vѮBwDwWKRIm0o~xDRyHb)5Mab_+E͛3ثOssz<T%{,0}9E,*A R~3 춰]@eV7q6~Tְ rB͜5YUrҋ[=#${•="jԛj2nj͡B.*__"<'W",TyuD˶Ͻ!?f{՝\HNΦJ˚/qCҫ~D9cRjH)V^?_f/l_瓫l> )[O^\Xcy_][ڡD@,ѷr_Ot' k _*v9|Fs_L%Ȩ ݸkj-V<*\7ڵҌDiQ}9#osBk=P*TP,%h}>ӫFZY3O7;3\)|DkUh.#I6{f{,tkY-ǝg<q=.QDZxn&Q33 Ip-#e3*z^Q9/e38/24ܷZ -HvߦJ#kO*Iky,m3z̲`bnư/ $8M-$]{iSҪI dRiEB"yzHi(٨y(O}hӛ4s%Gbf #x@PnxxƁJ )xۣZJ^:g] m2zIEw~[~!<ϲ5 r"8FnS„>@xqXav#ϾfF,5`?E@4tLLx60  ,"`1P,ꁥ2 ٗQմL:N)i> ٰnZ'kwYgqo2%y' w%둤Xm$F%['V,ZؾtK[}mim9ɜlz6,/ 64’˱}ՈoC#_5gYzmƉ<)2$vCARV;|Xh^Z[`Ieتrrrއδ1bxhjT+Ƞ+?19X"v8Kcso6iVCJw{sQ=؆v.q4ʣ7ﱴUUg/ /Ԫ7goy|MJdɷwA+ :L2 ;7o RYfs444iҚSnQT%'d9FA1;'N(͂i ]t %;M*)`P6JU =Kn~)**ėػG QS~T:Te#RKVƔ~&N7󙾞=b_0q'%F_84l߮Ijz 2$I:iW )¤j%CC*aҺ~?.Oet@@/6s iVE!؞ g7<5'6b6BkH{ gS_Fn( fП>qTg6yVr_ c~}{}aR?|b9{=S= JӜ$ǡ]* L^DW>\pڝ`Jueo R%h`Kag:?AR 富7˴y3P xm,V]2B>WsϗLj7n_T W#G$8 Wk9Dp1g+rvryg cyHeY!#17wbމ9HeBqDZ@cS>"S/wjڌ,.bu& UJŧW+4wZp! ߪd6(y#则W,Rvq\^㒳j2dY+`}BY|MfaV `6FmFAh㎠-q#2`mKwHC4ho!]W{ȢhkR~F'"hDspD#R)#Y'->zEvHgXD.ceh*p?]9-azFvߋE$Z4"0zVdDWX/GnIcDx\+v[Ujk-EpҞByuRh2hScOē?obHnlC[ehk 37 mVՍu-}=]~h;Z4c]Gh/KK{ٸhdmLS?e*eBOs:|_ Ĕl#/x_*o܍1#HtS`w yq#Yb~鰬ܞ;[H$ -Ga=n6d xX]l\G>3wvuܤ7k;/;M@F{qP)<'JErRxhP' EH@MC $C _߽{׉U@ |3̜s9g_own}"ɣ * фz|"iws%>z@%yP *`Pmh=3J] YKRpߧceq=ʥ_cᱷ߼?ؚrfij]:Oydxn55T~oW 硛֡mm]o <4II@Oy[-@=(<lg@#vI hZ@+ڍxw]@7R@/>ⳍOG =|$)0 FQ$p(1~}&MUX״hs ||Bđ *?9< TNGw/=fm:^QS'YĮt%T k%ӈhs"ٴ{xkok 1cS wvvG#ۑ>; GH5 ٕV8x1" %;jt"UX@xnȌA)R[ժSڋ 2 Gf2}G&KaTJLXp;iZ)Pwxi|n[u\STǯ#nh밎wʆTwl|uu]gKK鲔oUmTE0P4L2Yqu^YTjVVrid4-٦jcDK^w\j߯ΗmW3H׿̨|@ ~GXECRڡj*\{:D5-*5 ,(} cww(υ0Ue.0hlsm(Vo~q68v9ϒ,HVqGoy8 3<ފ~⾍Bnw*?ޟcW\ITSU%[&$S_a6D{@{S3sS seοK={[կO3.Ê~֫A?u<ƣ2y Ssz.U/5*7G}$$O[/Wɓu-.vEt{Q=n/q$S!Ro*Ek.izoП5}AUZ5/wdwUXnպL#-y|Wg} 3sT{l=/ȻmrPjr7bg0?|}Hd̞i'1G9[dio-:ڢ9ژ%-ih[M2=!HzC/c xX]l\G>3wv8&iN8q쬛cZj'ui {KԎب}HH!"H% T" "!~;w޵uHz7939?3s_wnEOGUT DyKac4M~$Ex=Ϋ'럡aNjU믃~yMvŧJ?덭B\TUfhג:hh=irX @#I`# x 4@$hO6`o;N`t< p%>ۈ~`xC(iY3s00 ze@/+~EJ+ZXS,F%G[ɖ--]cmg5ڐȘ3>o Gv|,j"ˑc=apƈܙT# N\*Q}}=uT[E#33 &v)JLx0'vҤs׊`ߝCG~Qq=܌wg+܋}|޳l֏_CR:)q?N]o5N ٠'۵r#[ZND}~FUQ EA#$'Uׯ_ RKEM'iy%6 EUƘK.aP*Q[ )bRt֯'Z%?~)=盄6NDIc'ۣKGΣ5RfƜ+l^0/ч~QR- i]/b3WOLZBvs 76'9W@%=|wϧsH=[4}{n5VܖB0=.G@Xer 8~q^OVNjGZHs!T<%r+`qlb*o닉SCp׃^uɐf4F-)6?ARކo惻Uxv-)μZG> eEo|[< am(o}xFBehFO/7qe;ll--jݜnčswW+y+aEE"9~~o#ZelcpU2b6ׇ*j0Sҏ;Z:\#Msj,ɂd'xw34 Ipy)V?jꋧZMV*=nU9Bkԛk6ޓBsy_&=NNL%F&^MΤ%v/ۗ8v޹ԯVZy|'!eks3z UuqG}LT aKbWDY޿%}ZSYzHY}wV034-.RZT{iqWN [mR(+񨰴Q,}W{ҪW]ve,^YSIVwe6;mkY;{qO;n6:.QpmƏefeI866aOx#`t▙Ⱥr\LbXdܷR!)k>$AJ"KO*IKp_+Хu\s_+X[ 8]_5y&DvA^ -eGYiu]i ܞ+yƣ5ǝa}퀕88XT(m=֣5I*pou3wc_mb~K5 Mb*{ۉmK>/*U*J mM\R*w޽kÚJH;sΙsΜ9gf.~f(|<[HPE& Iӿ[(,H=f cx^J 6UxZCy~oCxOѫѭzdW%fLx̯{iL#+~I|g1^Ҋ}yNgy;㳰>E/6ËdV`}UM%-_ #:RGQ>#Ljsh|h6&`3)hZ@ nۉw;t].`7O{}~p8&>ۈ#Qip!'OOz>4,O~(1^zuϥL% ܫִhs}ajrz2;<9yi4yl435cJIP̎}/G|vOuf{zOHTӁ_T8ܕnRjbM$rٗoIw67w n;x-kE'#2G? ׷;@a(%Zad9uPs'p8R)%qd :P*XAxlȈ%PlR{,2(K;idxd. # _z`\n8F ano4VWW{'߃A0B30ѷ ɻ6g8~itއuS.C~5;0*f@sz{ZAץD}~FUQ EA#$'So <4?_YM'i6 EUrxCf;Oy<ެ;[|)՗(3~Lx@=_tDL<¤Kݟp W›z'a&z}-t!_Emy6WR- ,Ӷ>糉M8^=aR*i-}?Ct\^|~ٯ6ϯZSX9 }ϧsH=[e̝@oFRghT^̱_үq=kpX$~d{馲t(Н,KwϬۋgBpxk׃]EGhȲwReroYOڏ?#.w͛؍ZiDS^)Ty!ϵE}%OG}mڢMjDIwHO#j8 p5V5oQk9ʻջy3aJUG%oywQj-*r J2q}UU >a`_8ut\lB & JNXu;fhܷ[hjycW\Ӌ*ųJ V)vyJ8O'@kG}#$'3%qcŽ_x}i;W4@C{1;+0rg(/2OBԙWgFƵ U/kU}M,ɧr:iW aOn./j9 ǽI2zhQ}w0鲸J2bQ^ܷ)Fw% k**r(zegƚ7;4Z'ym=-h:ǭs9ܷkYǽ丗qg#U}Tn9ᨇm]pv.BܸY[enY+eqJ|@C] #oBZ*"BH5PROZ[V-mVлdm-*oÑҨYk3|$u,@o! `Fx%a)֪4sPqG_ ڣg#T6UDHCEт#K j ==okut FVu J@!i}F }tQFi/ "[n=7/*{ ޮҟLUX[4 b9FSzҳ2}Ytw!5qHdL~-hOh휣-ehJ(*E: mwwҴ=!ڏ moC>p xX_pW?~I6)DZ²Ih'@ ;$K% i8/<`gY:NG AGъ%E3a~3[~=s=sǯ߼=<ϒG rh@=>4bђ=o a0w=jZ3:`%Poh=3@Pz"SFE@7+ƖmUM:%- UZl ZKڧOzxx 4$H@ lڀ6cw@ vi` ]Apl#z#sQK:hOO@8 H/y^{f?̾SfR[s6 D>::7Ut]JDW鏪6"ud?|~( y&?Kܸ}6^h("j?9M+*Fi(؈;K(z;rck~y~ |qti|+#r/K m)ts3* *+^_H_XZ^O^scL 'ߏ߰#*]Pv"ٽ 17QI3C%y*A/"34hYZL1->IRûMx6-$)˯*|ȱ}i_Dթ~?~OT2g;O,AC_q֯W_d6SoLόLhΫ_֨{O(YO ySO3-Y!:bg.%i=S37b ɳuX *(+^Vq}MZj\Ak*1+%d$K>#g]KnP֔V>iV|ۊ{H C`r0z9mFQSԾ*㋸Ύ~ui2g4n1#>1.D/ . +o)%pcHP/Dtlj1*IK,UKX|bm碑R;kV] ]^m2:̮+ yy\})JFP>X, Sȵ"YZWZ͠٪V {ľsߛuWjWwݝ/} (5{t!yi҇y|%g$QO+ƒ=Y qw#r YBOH啴 șH;$&b-%K{,̀f@;T@K['4v;qh?2ˆ N>{ xX]lUY^{{޶Z\n[(m2  3hLA b{i̴%Eー88$>8TF|VcdTs[E4!S{^k^{׿ZlKу|B4aH|>oO70{;@U] j hӔn{ފ>+W!f~.<ٚrFihY:O%I^Oz?]ZU5T~oW|'5}x2'tٷq -#V*V31Ah>4kuz $@ hZV`h[}@'9`/6.0px8 I E$@ ^^魇BOk\ʴy^ʽJM>A''&ׇG3*NVvlK7F&gDO8oeOr])F,K"}dy{ssgۂ-MV|22\7QymHM#~ٚV86cD@JH!N*Q]]=Щ2GfDex&ep&<ӇpiX xcS^ĻO NǛ`(eF#-i!'7dQP0ϣ:)kAO q--R"ʾIPQe#(hd~r9Kܸ}6^hP:=Oy4~WlPT5o333xlc4cB|v]LV40ZJyFU0J~ S56NMDJcgۣeKGTQmM1'`~^K$>ƼWзdkk6-?SR lӺ^YzLN bKUA ^;XwЯ ՐfIEq/3_]\-8a!jV4JTcm)ts32 ++^/ǀSW;X+*52׹lC$y dW$ۭgfIY!GK8yJA/W#i8{fx)ǐ |ʷ "}#>N*pօBiQz5#bw _o ZFպ9F]čc[啰E"٢ "gEWVh뼇XQ,; kTQf#u|ڻo nJSKŕ&dޠZ9K YI=սpF'g1}J/*O­jySp4!y<>&V7kmRBsy&=VJˌy%vǜ/ۗ%T\I,C#Ӭ_Ǔl< )Sߚc8r]>h:~dQ<-ޗu?->vCtzQ=v/q$SԸzE K*~RoygzcdV+cuʚ'VKo[qOo4WZǭu9kYeǽ丗qW=Uh}Tn9amݱߟ.BܸenY-'Ũ8)6ӀXd|HJy'IsX"K E ؤ;o:n9oX*յ_* f1@UUY/ޕU@FpI+Ҫ1Ү*p{T,flp6m+=qC`}PK^Oh]h7:ZsdiA^v SA@P_WHgk5PmhW]Ї }O^o{x 2J{C4ݪs3 }IM7YsS#cTj(ؿO.ro7Q,w19{ n~<(&>Cv휣s -)žPhZ A;D Ѿfh{CKg xX]lT>3w]}̲  *{?mK>DBڪ(JUSFi&J}nRR{ kJ+!.9g9s朙+~덿)r^1NU0PK$M^X'c5xͫ0exˁZCy>oCxOjd~Seo8?rFihI6OΧq<q.,J=T}3> 2l:Pnd WUؤX7#u *1}8' @#x X4$H@ lڀMfV@ lvi`' < Ftgt> <>"G~(1^򴙵vzuϧL IhZ9zG8915N̾2<FTOCuG5RF kÿ$^3;?}O]]ȼ7ΓѶky~i[w:0YB) Ŗ!A:"xnoan.NA7Fqk{Bk_\#8a kV4JmWr[ vL m{aK9T5|L|zXzn˔dܭ$^"Eu'*̀gfIďEiUӁxKxxUjׁ]EEF#i8`ye2k1GP |ʷ,&IJ__uDf)˯ΜF> 2G]^C.NpRma:5"b;g'15MCb_h7稷k9ʻջy3aUGeoYWVd`5n|t`A}RU]d@cUz_)&/g@+O M%3C%&Ʋeqcۄ! OKv޹:կ|_5=4ewVGO(YO uMO+=Y&:bJ2zhQ}w0iT\:Y1/G5} hQ ]cdܷ<3=0ʪvٙzM'MVIo[QG7UyYײ܋ǽq=nYHz_e"5[N0hcaW,Gc륗[nԬr[enY+Ũ8.Ҁdb@KuI$Y htX#k d U{(m,e`t ]VX,"4"88QpAlVWP|Uhp7z4zgJm͞ŷ~O#5BQ]ݦvt@3D6!jCg:/ôW Kӭzo=7/*{&]?#>52F˰V %i\JNۦ:.gi =C,~Tș8 &?"->$K,MG;xGKZR΋JѴC4mgCC}*/Cp xX]lT>3ww]}Ǹ&emo CCb mAe/ؠ4/t_P^ iҴ"UQj"UP*TT?l3?޽kuJ+Q.939sΙg~ Yra!NM%P(XrzF@%05xWkjCyA2%7åO"zTJEǂc7 ;Oٚr&htU:Oyd'8OW=s 53t>* ~hmC_Cu }Zl &i`3I`+f<mv` v{>`?p8H|(G:h^N//px8 ɬBEOk\ʴy^s3ӳ3Kc#c*??>VC;z&g؎xKXG9Įt+R k$ӈ`s2մkmV{1҂OƜRx658+,鳭tdT3 :9ۓ pR)5t UX@pnЌ>)PR[֪,R ڍ2Jfv2*|}Qqp28VAn8$,vz7T?xϟ!ʙ@|uB-YTk}ލ/QG?Rg' S5^׫Ij(ǽ[IхXk͍A>6i]_tYfȫV.X/[nBtT\#n%ٯ6ǭ|"ǝbӹJ`R݊& "w n5VܖBmǴchRV̱_>­{`דţFHl*Kv|ىdy+x O?W vv8+!U/gQd ]&IJſ(7ZIZ^8T:uh͊8dGKds]]U.¼jFIwތ ɟm]Kj^M}#k[数E"٢-77L$5nltaV`~AmRU֙b 6r.lF?P)&-74o %qњU[яYܷ13D$zy|u=J5[UvhBx|DUo:zmC? Zf|rt690Frpz23UY.|i_=-]WS'ʙGU(YY/3~GU_t6o^s9r^rOyKyҮ–En.'9D0{d*Y*OЎb ɳu\3*W)#NF, }MZjT@k*񨠴 W,}GFFi+O72\)|xku3~5w,},ǽq/z&[qySnjv z=m/}lb+]y-儘'Dq #oR*<B@<쟧Z%%"l*<:x)X[K{KoφC^ژgv:vlF #I˕)Ҫ0 Ү+p{B,gllڨKVz8⬇`Ekg3zm.͒qCLh{ςV“EHD6%RHT2K*U-UժDo-*U)UTl3?w]hΜ9sΙ3g̽|?P|)H& Tid2`?C:h@px8Gc _)ffݧMǕմ8==O%ӱcgb$*>3L>UmiK!fƞ[KK<_t +y=%͸jbun 1o744ns9T;L+gtҫTHϒK璐ő3 ԑ7y{*o*UtUZ2:8K16 jlF/MO'WHMR?Bak9o4I-[5@'3dž2;=tgI':$~ DLqG%|VU?=<}=N^Guu߭-=/VgI$+njME uo5 m&пBQ!;EV/%ꍩL Z.:4!y ZT mcXycGc}#S\Ȓ[8\8)K ">1-%ٖ]W.~!e L]OZt?BƝNXs5ȭK2Tǿd;F'$ gN4IJK'%eZpjӉZKuDٱTn>n3=0RJA`3cɫ5I jm-hᯖ~o;GtɯW1wm{^TES~vł~>VV|fUr ostW;p+3NKx"eoC-Q&--x(X<[<X[`uKB~ gRŤo@Jp{1EӉѝ6XG= X=b,.p^(FzJ;@JpGk1܆nY<HAWGnS|"w)qs D:T-JK% ,W5j Of9l^էey/ۣ_ԫW{S9=nVVuho%K iC5çp^iEeti3>mƧ HKyYQէ&QFxo(]5Q>;%[%Yo gsT$VKq7M;`%Jr07ci9f-$8 >ojM̞^QZ+WH||bGx-*|r}(sj?/*< xY[ls\j 1a Rj6 1Je&6K)O"!9Ҵ%<*TUriUwZ)!!*mI~snX#Z )33gf̜o~%e^)A!0PO$M^TH8u@H^ zh4ϟ'<~ t : 4b.T뚽',{GM잲hxN6Oϧq߉YqN=T}3> "ls^|$l76*Iݾgv0?@D Iǔ,%Ri`i`9@'xV^k^`gMf` l#;瀝.`7 |*<5@?0/z2D30y/6K KjZts􏞜OsމّΑDAUFsg٣=">Y{L{q5Wu?+v%SҕXXK,F vWz+[Dͧ#2> <, KvcjķQC*mpc]ƉԶMIl, <|XdnZKܤ2jU9Yf/Py:VGuD^(eq&<p{hDAƱN"x8mďK [[sPm2Rúީ~2k<"x=ڵZ,%{7E0P4L2EquОLfffJ4==i4ݦJo̔3`O)YwD!͘rPK.aQf* 0Z1Qtj 1ҧ W m+|%}To/S;j{tf^O{8 ;DOTl~o>dqTMWD˿.eFHӶlbWOL<^oBvS <7!=~y~=[RQX ] >"voEct{uJVYnKK۞iעmo Hy2~9:y$ϧqH)ɄI9MU.Q;Yn?MLM4~c{1qXB(^!N_jz˷1 YbY:]X |w,IJ[⇥yJkڇh+Zg^smCQ {|o|[< ĵrmQ25"bsH& -\Cb_ki7ר5qcmBLأJQ?EK&|\"^A TL8.ϋB*b0StyD&[N& JNXu;fhܷr [h0<cV\ӋI!ܪW:[ Gg1Ѡ޼j=#^06ǶʏL}{-88:><~9=Ϟk^#8^8=/~sfhOT3hJ>Tg$/2[OBʶ' ZUj7~dE=ޗ5~ZBؓE?_=>s$OqȿenjOH7x3NceEˊ;rLpZӧZ޷a5+TX8 X},e-vQc~5;}uV{l`c#XWڶ)ZEWykYZv`;ZzA'Ga}rHlW'Oog=iElPߑo_3C D]ʟulUs*rGFi/ ~W"7iw='RǷ{#~,}d8ld 缚YKzg37ٞ{ĺ r&'q)7-]q+vHZ!ﮣݕT^o('M"zJ kB!RƲ'?&F:pW:UoZu03w] 85,!f(5 Mb(4*76Yb"Ud_RiI(RU*5Tm$'r>?y(jJ;sݻD13g9sΙ3soh#ڗȡ8h@5HRɒK'FZ $XIh0ۓF(?RBN^5ػk!#&lБK(mu/ ]4iW kȾT{Ƕtg6E7F3̸ o 2œ[}6UrVH5Q=%eg>]q^l, 8|Zh m-PR[֪,S<0 ڍPmeTLGexTzQqp28=ˇ҄6FݝE|U38>ی3D53Zi6G}lCH-uN` Joq˄= d>m~-R"˾ORQ(RG燢S`U(ĝ[nR%ZZ*‚qjZI7MGQY*10\")bnO-Qzi tp3@EvJ~Ŭ*iZJAU0Jn#nt)&Sb+O#"S]$R䴃P0Cwv}MRR3vRMw1x?8'R Die_wYz9X 5,]7P"σtX#Ia0K<.tֻ|<'EzpԵh携֯x:~ Gl/OGMzE0)1*\?gm8!ȦdȗJ&'? 8>/ Oj:ױV;]rS$pJe<6EK:o;hNrSQh#.GS. ½NCz5#xFJe9k+mCb[khZ7W6qej6#oy%lQHh"ubZF!6nT 8AW&\a [O pjwH#E.'6j,ɂdⓞxnus"esrtI0I[ MS'F8a'1Tp/)o~{q&$;#^=yK66<}O6#h멑tbYr?K">S}kA8́Ki)%h+*Gxydu>棐jn?'+-.'=~[Cؒȼszm/Iy?eTyֆ5+OH\:Qa^)q2"d9%jӇUϻJ hvߙuU?XrI5^lFEgG omFySOEv$ qZV`4j\=嘘DI #J)Ԗy"EؿH-J"KZ d ٤z,ӥu,Yf4KgÁJYmaCfC+WzGi #?{M ݑܨW-u\ķِ4#Jdvr>< Ʊs#r2{M2/&>yq̧]6= K6=)ii3p: *4G3b|l>S|\AMeSn.?,9$߷dk: xYolTY?韙`e)ô@e ˿m.K:iapf~&m051 '57bt b/(sy}߼ι=sOKcJj#4e!OJȕz$&pxz ey 7M@}p=4˸x)jA8]\z-ۆ}87ޛ*\M9FhxI6Wgr+? 8G]'`k iiX/Ey쳯\럻q e$[-V)Ok X |xX<Zu@Xd6l:_o[.Y`; |xmD>`?p8"G灏GO~p8 'S xFeεg{9c,0Z/ehy7zT+GJ+##ҸdבF0,sb>9<oNTݫV2rW|jZi4/3Оδmikڴg#|Ԛ؀O|j`§7ю]q}pX>gvKCәv^DHlH}CPElXLԾIeܪ8Ye7T'b!Ae(zV^prvH2u fqڟηt{oWˣqi5hS7M~R9gezD 2ȃ/zIΓu^(hde&nܾ}7') MMM_yC~6*pG cIdINκNOތI Iz*ry)Y`RZҠ,5ƌ?AJEUxFk󤟐{^kͻJ#^Kܟ~_L6$sDWJs ܹl^bOHu$i ?Woz IfqЮ[Ǥuĭ_!vƯ[`^k~Z;M3)+_٥7=qkhoǠGJ*ɛcKד{Fbƥ벙Ld9 =ʠ \!pHzpGQJG1PeIG< x}C`YKi$b[ A$3o4im^ n"b7:ckB"B}kf>l3,⼵"X"͑sWgQ9fQC$ˈ9;(g'Fc`_f*c_3_;qeKU$衷QjVx+#+)*(SgF0{XsdɁtȰ=s]82<$7ZoO %@iRD2ʼ?-U+rނ[@6dՆڲ <>xmʐ5{\x0_| uGWQG p{B-&"zވ88GyY7kDUcֈBGzPP<[Dt`k Azn ~q=E:3ì+ W;Wa^+ ^O@ ]rƽʖha=k4S-5v+KF7 ]u {(!]2m1W-=1z3av(*>hŴ}"2ǎ:jB5RohW}/ k>,c$uBE/׋D*>Fh1{;.cEՀ%F_ȶԫ]sP,Q-Lͬ˽N|2|~4witl<<W9caxCEfN37W wpr@jfU%0s(\y 03*70t:E`1=.AMR6DGSKNRuUKZS^a *3h(  ,  o Chart MSGraph.Chart.80*Microsoft Graph Chart0dOh+'0Q `h   $Apresentao do PowerPointCentro Estudos Pediatria EPMtAllan Korosue P14aMicrosoft PowerPointria@PgƮ(@fm@n;@ }5KGPg  R('& &&#TNPP2OMi & TNPP &&TNPP     'A x(xKʦ """)))UUUMMMBBB999|PP3f3333f333ff3fffff3f3f̙f3333f3333333333f3333333f3f33ff3f3f3f3333f3333333f3̙33333f333ff3ffffff3f33f3ff3f3f3ffff3fffffffff3fffffff3f̙ffff3ff333f3ff33fff33f3ff̙3f3f3333f333ff3fffff̙̙3̙f̙̙̙3f̙3f3f3333f333ff3fffff3f3f̙3ffffffffff!___www'''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''HkHkHHHkHkHkHHHkHkHkHHHkHkHkHHHkHk''''''''''''''''''''''''''''''''''''''''''kHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHHHkHkHkHHHkHkHkHHHkHkHkHHHkHkHkHHHkHkHkHHHkHkHkHHHkHkHkHHHkHkHkHHHkHkHkHHHkHkHkHHHkHkHkHHHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkHHHkkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHkHHkHHHkHHHkHHHkHHHkHHHkHkHHHkHHHkHHHkHHHkHHHkkHkHkHkHkHkHkHkHkkHkHkHkHkHkHkHkHHkHkHHHkHkHkHHkHkHkHHHkHkkHkHkHkHkHHkHkHkHkHHkHHHkHHHkHHHkkHkHkHkHkHHkHkHkkHHHf______f_f___f___f_f_______f_f___________f_f_f_f_f_______f_f__f--&TNPP &%_d Allan KorosueAllan Korosue     Apresentao na telapre2 Times New RomanEstrutura padroMicrosoft Graph Chart-Nmero de Questionrios Enviados e RecebidosZPorcentagem de carta-resposta em relao ao nmero enviado de acordo com a regio do pas_1. Voc aprendeu algo sobre Imunodeficincia primria na Universidade ou durante a residncia?i2.Aps o trmino da residncia mdica voc tem ouvido ou aprendido algo sobre imunodeficincia primria?/3. Atende pacientes com infeco de repetio?>4.Voc atende pacientes que usam antibitico com freqncia? d5.Voc sabia que pacientes que usam antibitico com freqncia podem ter imunodeficincia primria?Z6. Alguma vez voc j investigou algum dos seus pacientes para Imunodeficincia Primria?7.Se voc quiser avaliar um paciente com suspeita de imunodeficincia e necessita orientao sobre os exames laboratoriais, voc sabe a quem solicitar essas informaes?V8. Voc acha que todo paciente com Imunodeficincia Primria est gravemente enfermo?O9. Voc sabia que tem tratamento para pacientes com Imunodeficincia Primria?o10. Voc sabia que pacientes com Imunodeficincia Primria no devem receber vacinas de microorganismos vivos?T11. Qual a maior dificuldade para investigar o sistema imunolgico do seu paciente?M12. Tem interesse em obter mais informaes sobre imunodeficincia primria?13. Aps ler os sinais de alerta, voc acha que alguns dos seus pacientes necessita ser investigada para imunodeficincia primria?Envio de comentrio Fontes usadasModelo de estruturaServidores OLE incorporadosTtulos de slidesncorporadosTtulos de slides%_ ~Allan KorosueAllan Korosue  !"#$%&'()*+,-./123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root EntrydO)q5KPictures_Current User GSummaryInformation(RPowerPoint Document(0DocumentSummaryInformation8U Chart MSGraph.Chart.80*Microsoft Graph Chart0b W Chart MSGraph.Chart.80*Microsoft Graph Chart0`I Chart MSGraph.Chart.80*Microsoft Graph Chart0fD Chart MSGraph.Chart.80*Microsoft Graph Chart0^o Chart MSGraph.Chart.80*Microsoft Graph Chart0\q Chart MSGraph.Chart.80*Microsoft Graph Chart0Zr Chart MSGraph.Chart.80*Microsoft Graph Chart0hs Chart MSGraph.Chart.80*Microsoft Graph Chart0Vt Chart MSGraph.Chart.80*Microsoft Graph Chart0T u Chart MSGraph.Chart.80*Microsoft Graph Chart0R!v Chart MSGraph.Chart.80*Microsoft Graph Chart0P"w Chart MSGraph.Chart.80*Microsoft Graph Chart0N%x Chart MSGraph.Chart.80*Microsoft Graph Chart0L&y Chart MSGraph.Chart.80*Microsoft Graph Chart0J'z Chart MSGraph.Chart.80*Microsoft Graph Chart/ 0LDTimes New Romanc|dv 0|( 0 ` . @n?" dd@  @@`` ,$LY      /"$Ayٓ8UR>"$[sF92a-X>$"$=^u]U '-"$j|`] Q#T"$}6m)Y"v|w "$[d]Ǫ˰. gO!c*"$=23L'DT6UD"$h'ZM,J"$ꌬMp6%U$O"$iڱi2'%0T"$_wrW^t2 Zc $@fff@7uʚ;2Nʚ;g4\d\dv 0pppp@ <4!d!d` 0,c<4dddd` 0,c ? ,Nmero de Questionrios Enviados e Recebidos--YPorcentagem de carta-resposta em relao ao nmero enviado de acordo com a regio do pasZZ ^1. Voc aprendeu algo sobre Imunodeficincia primria na Universidade ou durante a residncia?__ h2.Aps o trmino da residncia mdica voc tem ouvido ou aprendido algo sobre imunodeficincia primria?ii.3. Atende pacientes com infeco de repetio?//=4.Voc atende pacientes que usam antibitico com freqncia? >>c5.Voc sabia que pacientes que usam antibitico com freqncia podem ter imunodeficincia primria?ddY6. Alguma vez voc j investigou algum dos seus pacientes para Imunodeficincia Primria?ZZ 7.Se voc quiser avaliar um paciente com suspeita de imunodeficincia e necessita orientao sobre os exames laboratoriais, voc sabe a quem solicitar essas informaes? U8. Voc acha que todo paciente com Imunodeficincia Primria est gravemente enfermo?VV N9. Voc sabia que tem tratamento para pacientes com Imunodeficincia Primria?OO# n10. Voc sabia que pacientes com Imunodeficincia Primria no devem receber vacinas de microorganismos vivos?oo$ S11. Qual a maior dificuldade para investigar o sistema imunolgico do seu paciente?TT(L12. Tem interesse em obter mais informaes sobre imunodeficincia primria?MM)13. Aps ler os sinais de alerta, voc acha que alguns dos seus pacientes necessita ser investigada para imunodeficincia primria?*Envio de comentrior T*C !